Journal Published Online: 01 May 2003
Volume 48, Issue 3

Zaleplon and Driving Impairment

CODEN: JFSCAS

Abstract

Zaleplon, a sedative-hypnotic, was identified in the blood of a subject arrested for impaired driving. Symptoms reported were those of central nervous system (CNS) depression. The zaleplon concentration was determined to be 0.13 µg/mL. Symptoms included slow movements and reactions, poor coordination, and lack of balance. Although no quantitative relationship between blood concentrations and degree of driving impairment is currently possible, it is reasonable to conclude that because of its specific activity as a sedative-hypnotic, blood concentrations consistent with doses exceeding therapeutic concentrations of zaleplon have the potential to cause impairment of psychomotor function, and would impair a person's level of consciousness and driving ability.

Author Information

Stillwell, ME
Oklahoma State Bureau of Investigation, Oklahoma City, OK
Pages: 3
Price: $25.00
Related
Reprints and Permissions
Reprints and copyright permissions can be requested through the
Copyright Clearance Center
Details
Stock #: JFS2002357
ISSN: 0022-1198
DOI: 10.1520/JFS2002357